BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)

CUSIP: 07725L102

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
-795,236
Put/Call ratio
41%
SEC-reported price per share
$224.51
Indexed holders
221
Value change
-$116,771,313
Number of buys
99
Open additional details 1 more signal available
Number of sells
110
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,501,807,694

Security key

07725L102

Report period

Q3 2024

Indexed institutions

221

Top holders

10

Ownership snapshot

Top reported holders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AMGEN INC
Disclosed value leader
AMGEN INC
Comparable rows
0/15
Latest evidence
01 Jul 2024
3/4/5 13F Highest disclosed value: $3,419,356,261 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

AMGEN INC has the largest disclosed position value at $3.42B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AMGEN INC's linked filing trail.
Disclosed position value Top 5
AMGEN INC $3.42B
BAKER BROS. ADVISORS LP $1.51B
Capital International Investors $1B
HHLR ADVISORS, LTD. $738.59M
PRIMECAP MANAGEMENT CO/CA/ $711.39M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AMGEN INC
3/4/5
10%+ Owner
—
denominator unverified
$3,419,356,261
18,943,802 shares
— 10 Sep 2021
BAKER BROS. ADVISORS LP
13F
Company
13F
—
denominator unverified
$1,507,864,535
10,568,897 shares
— 30 Jun 2024
Capital International Investors
13F
Company
13F
—
denominator unverified
$1,002,125,786
7,013,568 shares
— 30 Jun 2024
HHLR ADVISORS, LTD.
13F
Company
13F
—
denominator unverified
$738,589,179
5,176,906 shares
— 30 Jun 2024
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
—
denominator unverified
$711,393,852
4,986,289 shares
— 30 Jun 2024
Donald W. Glazer
3/4/5
Director
—
mixed-class rows
$564,671,459
2,752,615 shares
mixed-class rows
— 05 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
221
Shares
46,519,526
Indexed holders
221
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 indexed holders
195
Q3 2024 indexed holders
221
Indexed holder difference
26
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .